Patent details

EP2293797 Title: PROGESTERON ANTAGONISTS SUCH AS CDB-4124 FOR REDUCING PAIN ASSOCIATED WITH ENDOMETRIOSIS AND UTERINE FIBROIDS

Basic Information

Publication number:
EP2293797
PCT Application Number:
PCT/US/2009/041826
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097395206
PCT Publication Number:
WO/2009/134718
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROGESTERON ANTAGONISTS SUCH AS CDB-4124 FOR REDUCING PAIN ASSOCIATED WITH ENDOMETRIOSIS AND UTERINE FIBROIDS
French Title of Invention:
ANTAGONISTES DE LA PROGESTÉRONE TELS QUE CDB-4124 POUR DIMINUER LA DOULEUR ASSOCIÉE A L'ENDOMÉTRIOSE ET LES FIBROMES UTÉRINS.
German Title of Invention:
PROGESTERON-ANTAGONISTEN WIE CDB-4124 ZUR SCHMERZLINDERUNG IN ZUSAMMENHANG MIT ENDOMETRIOSE UND GEBÄRMUTTERFIBROIDEN
SPC Number:

Dates

Filing date:
27/04/2009
Grant date:
11/11/2015
EP Publication Date:
11/11/2015
PCT Publication Date:
05/11/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2011
EP B1 Publication Date:
11/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/04/2016
Expiration date:
27/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/04/2009
 
 

Name:
Repros Therapeutics Inc.
Address:
2408 Timberloch Place, B-7, The Woodlands, TX 77380, United States (US)

Inventor

Name:
PODOLSKI Joseph, S.
Address:
United States (US)

Priority

Priority Number:
48472 P
Priority Date:
28/04/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/573;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages